Cardinal Health (CAH) insider trading
Insider activity, historical context and SEC filings · data through Nov 20, 2026
No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.
Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.- Next earnings expected around Feb 11, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Sale Jason M. Hollar, CEO sold 29,915 shares at $235.51 ($7.0M).
- Trade date
- Aug 18, 2026
- Disclosed to the SEC
- Aug 20, 2026
- Type
- Sale (code S)
Read the original SEC filing ↗All CAH insider trades ↓
Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.
CAH insider transactions (Form 4)
Open-market purchases and sales. 53 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 20SEC | Jason M. HollarCEO | Sell | 29,915263,810 held (−10%) | $235.51 | $7.0M | +16.9% | — |
| Aug 20SEC | Jason M. HollarCEO | Sell | 21,407293,725 held (−7%) | $234.56 | $5.0M | +17.3% | — |
| Aug 20SEC | Jason M. HollarCEO | Sell | 16,187196,847 held (−8%) | $237.23 | $3.8M | +16.0% | — |
| Aug 20SEC | Jason M. HollarCEO | Sell | 16,208247,602 held (−6%) | $236.54 | $3.8M | +16.4% | — |
| Aug 20SEC | Aaron E. AltCFO | Sell | 13,68533,467 held (−29%) | $236.58 | $3.2M | +16.3% | — |
| Aug 20SEC | Aaron E. AltCFO | Sell | 12,97220,495 held (−39%) | $237.26 | $3.1M | +16.0% | — |
| Aug 20SEC | Stephen M. MasonCEO | Sell | 12,82918,061 held (−42%) | $237.26 | $3.0M | +16.0% | — |
| Aug 20SEC | Jason M. HollarCEO | Sell | 12,470235,132 held (−5%) | $237.25 | $3.0M | +16.0% | — |
| Aug 20SEC | Aaron E. AltCFO | Sell | 12,22847,152 held (−21%) | $235.54 | $2.9M | +16.8% | — |
| Aug 20SEC | Jessica L. MayerGeneral Counsel | Sell | 10,86433,076 held (−25%) | $237.31 | $2.6M | +16.0% | — |
| Aug 20SEC | Stephen M. MasonCEO | Sell | 10,87630,890 held (−26%) | $236.50 | $2.6M | +16.4% | — |
| Aug 20SEC | Jessica L. MayerGeneral Counsel | Sell | 10,24648,366 held (−17%) | $235.51 | $2.4M | +16.9% | — |
| Aug 20SEC | Stephen M. MasonCEO | Sell | 8,19541,766 held (−16%) | $235.62 | $1.9M | +16.8% | — |
| Aug 20SEC | Jason M. HollarCEO | Sell | 6,731213,034 held (−3%) | $236.46 | $1.6M | +16.4% | — |
| Aug 20SEC | Deborah WeitzmanCEO | Sell | 6,66578,590 held (−8%) | $235.30 | $1.6M | +17.0% | — |
| Aug 20SEC | Jason M. HollarCEO | Sell | 6,244190,603 held (−3%) | $237.88 | $1.5M | +15.7% | — |
| Aug 20SEC | Jason M. HollarCEO | Sell | 6,206228,926 held (−3%) | $233.22 | $1.4M | +18.0% | — |
| Aug 20SEC | Jason M. HollarCEO | Sell | 5,704219,765 held (−3%) | $235.34 | $1.3M | +16.9% | — |
| Aug 20SEC | Michelle D. GreeneChief Information Officer | Sell | 4,95214,528 held (−25%) | $235.68 | $1.2M | +16.8% | — |
| Aug 20SEC | Jessica L. MayerGeneral Counsel | Sell | 4,42643,940 held (−9%) | $236.38 | $1.0M | +16.4% | — |
| Aug 20SEC | Jessica L. MayerGeneral Counsel | Sell | 3,90058,612 held (−6%) | $234.64 | $915K | +17.3% | — |
| Aug 20SEC | Michelle D. GreeneChief Information Officer | Sell | 3,51211,016 held (−24%) | $236.31 | $830K | +16.5% | — |
| Aug 20SEC | Jason M. HollarCEO | Sell | 3,457225,469 held (−2%) | $234.29 | $810K | +17.5% | — |
| Aug 20SEC | Aaron E. AltCFO | Sell | 3,11559,380 held (−5%) | $234.55 | $731K | +17.3% | — |
| Aug 20SEC | Stephen M. MasonCEO | Sell | 3,10049,961 held (−6%) | $234.59 | $727K | +17.3% | — |
| Aug 20SEC | Michelle D. GreeneChief Information Officer | Sell | 2,50019,480 held (−11%) | $234.57 | $586K | +17.3% | — |
| Aug 20SEC | Mary C. SchererChief Accounting Officer | Sell | 2,2022,811 held (−44%) | $237.39 | $523K | +15.9% | — |
| Aug 20SEC | Michelle D. GreeneChief Information Officer | Sell | 68610,330 held (−6%) | $237.25 | $163K | +16.0% | — |
| Aug 20SEC | Deborah WeitzmanCEO | Sell | 40878,182 held (−1%) | $236.59 | $97K | +16.3% | — |
| Aug 20SEC | Deborah WeitzmanCEO | Sell | 28177,901 held (−0%) | $237.44 | $67K | +15.9% | — |
| Aug 20SEC | Mary C. SchererChief Accounting Officer | Sell | 1005,013 held (−2%) | $237.40 | $24K | +15.9% | — |
| Mar 3SEC | Michelle D. GreeneChief Information Officer | Sell | 2,64612,230 held (−18%) | $228.47 | $605K | +20.5% | — |
| Mar 3SEC | Michelle D. GreeneChief Information Officer | Sell | 10014,876 held (−1%) | $228.55 | $23K | +20.4% | — |
| Feb 18SEC | Aaron E. AltCFO | Sell | 2,32826,408 held (−8%) | $225.50 | $525K | +22.0% | — |
| Feb 10SEC | Patricia Hemingway HallDirector | Sell | 4,00028,264 held (−12%) | $229.72 | $919K | +19.8% | — |
Similar past setups: not applicable. CAH has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →
Play with CAH in the Research Lab
CAH has no open-market insider buys in the last 12 months. Try the tools with any setup.
Quick backtest: did buys like this beat the market?
Tap a setting to see how 6,290 past insider buys did.
Share price and insider trades
Cardinal Health insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 8 sold $61.6M of CAH stock on the open market; P/E 35.6 vs. a sector median of 25.0.
By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this
CAH insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $59.6M | 31 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $2.1M | 4 |
Valuation, profit and volume
Source: SEC filings, as of Nov 16, 2026. Volume and paper profit use daily closing prices.
Summary
Over the past 12 months, 0 Cardinal Health insiders reported open-market purchases totaling $0, while 8 insiders reported sales totaling $61.6M. 0 of 35 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
CAH earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Nov 5, 2026 | +1.7% | None | +3.7%S&P -4.1% | pending |
| Aug 11, 2026 | +4.0% | None | -1.3%S&P -0.1% | +0.2% |
| Apr 30, 2026 | -5.6% | None | -3.7%S&P +1.3% | +0.8% |
| Feb 5, 2026 | -1.7% | None | +9.4%S&P +0.6% | -3.8% |
| Oct 30, 2025 | +6.7% | None | +16.0%S&P -0.8% | +11.3% |
| Aug 12, 2025 | +0.3% | None | -6.1%S&P +1.4% | +2.8% |
| May 1, 2025 | +5.2% | None | +5.8%S&P +2.2% | +3.3% |
| Jan 30, 2025 | +3.0% | None | -3.2%S&P +0.0% | +4.7% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
CAH short selling
Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.
This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →
Members of Congress who traded CAH
From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.
| Member | Trade | Traded | Reported | Since trade |
|---|---|---|---|---|
| Alan ArmstrongSenate | Bought $1,001 - $15,000 | Mar 27, 2026 | Jul 21, 2026 | +34.1% |
Insiders at Cardinal Health
| Insider | Bought | Sold | Last filing | Past buys beat S&P | Score |
|---|---|---|---|---|---|
| Jason M. HollarCEO | — | $29.4M | Aug 20, 2026 | — | — |
| Aaron E. AltCFO | — | $10.5M | Aug 20, 2026 | — | — |
| Stephen M. MasonCEO | — | $8.3M | Aug 20, 2026 | — | — |
| Jessica L. MayerGeneral Counsel | — | $7.0M | Aug 20, 2026 | — | — |
| Michelle D. GreeneChief Information Officer | — | $3.4M | Aug 20, 2026 | — | — |
| Deborah WeitzmanCEO | — | $1.7M | Aug 20, 2026 | — | — |
| Patricia Hemingway HallDirector | — | $919K | Nov 16, 2026 | — | — |
| Mary C. SchererChief Accounting Officer | — | $546K | Aug 20, 2026 | — | — |
| Robert AzelbyDirector | — | — | Nov 16, 2026 | — | — |
| Christine MundkurDirector | — | — | Nov 16, 2026 | — | — |
| David C. EvansDirector | — | — | Nov 16, 2026 | — | — |
| Robert W. MusslewhiteDirector | — | — | Nov 16, 2026 | — | — |
| Sheri H. EdisonDirector | — | — | Nov 16, 2026 | — | — |
| Sudhakar RamakrishnaDirector | — | — | Nov 16, 2026 | — | — |
| Akhil JohriDirector | — | — | Nov 16, 2026 | — | — |
| Nancy KilleferDirector | — | — | Nov 16, 2026 | — | — |
| Michelle BrennanDirector | — | — | Nov 16, 2026 | 1 of 1 | — |
| Valerie Christine PitteroffChief Human Resources Officer | — | — | Aug 18, 2026 | — | — |
| Ola M. SnowChief Human Resources Officer | — | — | Dec 2, 2025 | 1 of 1 | — |
| Gregory B. KennyDirector | — | — | Nov 6, 2025 | — | — |
Board links: companies that share insiders with CAH
Directors and executives who filed Form 4s for CAH and another company in the last 12 months.
- BABoeing Akhil Johri Director here · Director at BA · latest filing Nov 18, 2026
- CSGPCoStar Group Robert W. Musslewhite Director here · Director at CSGP · latest filing Nov 16, 2026
- DVADaVita Jason M. Hollar CEO here · Director at DVA · latest filing Nov 17, 2026
- KDPKeurig Dr Pepper Aaron E. Alt CFO here · Director at KDP · latest filing Aug 27, 2026
- METAMeta Platforms Nancy Killefer Director here · Director at META · latest filing Nov 16, 2026
- SMGScotts Miracle-gro David C. Evans Director here · Director at SMG · latest filing Nov 16, 2026
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
CAH stock: common questions
Are Cardinal Health insiders buying CAH stock?
No. No Cardinal Health insider reported an open-market purchase of CAH in the past 12 months.
Are Cardinal Health insiders selling CAH stock?
8 insiders reported sales worth $61.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CAH's P/E ratio?
CAH trades at about 35.6 times trailing earnings, compared with a median of 25.0 for the Health Care sector.
What is CAH's 52-week range?
Over the past year CAH has traded between $181.68 and $283.85. It last closed at $275.21 on Nov 20, 2026.